Drug Shortage Report for ALOXI
| Report ID | 145567 |
| Drug Identification Number | 02381729 |
| Brand name | ALOXI |
| Common or Proper name | palonosetron hydrochloride |
| Company Name | KNIGHT THERAPEUTICS INC. |
| Market Status | DORMANT |
| Active Ingredient(s) | PALONOSETRON |
| Strength(s) | 0.5MG |
| Dosage form(s) | CAPSULE |
| Route of administration | ORAL ORAL |
| Packaging size | 1 |
| ATC code | A04AA |
| ATC description | ANTIEMETICS AND ANTINAUSEANTS |
| Reason for shortage | Requirements related to complying with good manufacturing practices. |
| Anticipated start date | 2021-09-13 |
| Actual start date | 2021-09-13 |
| Estimated end date | 2021-09-30 |
| Actual end date | 2021-09-24 |
| Shortage status | Resolved |
| Updated date | 2021-09-25 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 100 ALEXIS-NIHON BLVD., SUITE 600 MONTREAL, QUEBEC CANADA H4M 2P2 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v6 | 2021-09-25 | English | Compare |
| v5 | 2021-09-24 | French | Compare |
| v4 | 2021-09-24 | English | Compare |
| v3 | 2021-09-14 | English | Compare |
| v2 | 2021-09-13 | French | Compare |
| v1 | 2021-09-13 | English | Compare |
Showing 1 to 6 of 6